Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sakamoto, J; Kodaira, S; Hamada, C; Ito, K; Maehara, Y; Takagi, H; Sugimachi, K; Nakazato, H
   An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer
   ONCOLOGY REPORTS
   
   J. Sakamoto et al., "An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer", ONCOL REP, 8(3), 2001, pp. 697-703
2. Nakamura, T; Ohno, M; Tabuchi, Y; Kamigaki, T; Fujii, H; Yamagishi, H; Kuroda, Y
   Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   T. Nakamura et al., "Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III", INT J ONCOL, 19(2), 2001, pp. 291-298
3. Osterlund, P; Elomaa, I; Virkkunen, P; Joensuu, H
   A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer
   ONCOLOGY
   
   P. Osterlund et al., "A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer", ONCOL-BASEL, 61(2), 2001, pp. 113-119
4. Nagawa, H; Muto, T; Sunouchi, K; Higuchi, Y; Tsurita, G; Watanabe, T; Sawada, T
   Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy
   DISEASES OF THE COLON & RECTUM
   
   H. Nagawa et al., "Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy", DIS COL REC, 44(9), 2001, pp. 1274-1280
5. Ito, K; Kato, T; Koike, A; Miura, K; Yamaguchi, A; Sakou, T; Takagi, H
   Optimum duration of oral adjuvant chemotherapy of HCFU for colorectal cancer; Review of 5-year follow-up
   ANTICANCER RESEARCH
   
   K. Ito et al., "Optimum duration of oral adjuvant chemotherapy of HCFU for colorectal cancer; Review of 5-year follow-up", ANTICANC R, 20(6C), 2000, pp. 4681-4686
6. Iwagaki, H; Tanaka, N; Esato, K; Kaibara, N; Sano, K; Dohi, K; Nakamura, T; Nakasato, H; Orita, K
   Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU aloneas postoperative adjuvant chemotherapy for colorectal cancer
   ANTICANCER RESEARCH
   
   H. Iwagaki et al., "Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU aloneas postoperative adjuvant chemotherapy for colorectal cancer", ANTICANC R, 20(5C), 2000, pp. 3727-3734
7. KAN S; MORIYA F; ISHIZU H
   EFFECTS OF ANTINEOPLASTICS, ANTIBIOTICS AND ANTIDIABETICS ON ACETALDEHYDE METABOLISM AFTER ALCOHOL INGESTION
   Acta medica Okayama
   
   S. Kan et al., "EFFECTS OF ANTINEOPLASTICS, ANTIBIOTICS AND ANTIDIABETICS ON ACETALDEHYDE METABOLISM AFTER ALCOHOL INGESTION", Acta medica Okayama, 52(1), 1998, pp. 9-17
8. SATO S; HIROTANI Y; OGURA N; SASAKI E; KITAGAWA S
   ENHANCING EFFECT OF N-DODECYL-2-PYRROLIDONE ON THE PERCUTANEOUS-ABSORPTION OF 5-FLUOROURACIL DERIVATIVES
   Chemical and Pharmaceutical Bulletin
   
   S. Sato et al., "ENHANCING EFFECT OF N-DODECYL-2-PYRROLIDONE ON THE PERCUTANEOUS-ABSORPTION OF 5-FLUOROURACIL DERIVATIVES", Chemical and Pharmaceutical Bulletin, 46(5), 1998, pp. 831-836
9. ITO K; YAMAGUCHI A; MIURA K; KATO T; BABA S; MATSUMOTO S; ISHII M; TAKAGI H
   ORAL ADJUVANT CHEMOTHERAPY WITH CARMOFUR (HCFU) FOR COLORECTAL-CANCER- 5-YEAR FOLLOW-UP, TOKAI HCFU STUDY-GROUP - 3RD STUDY ON COLORECTAL-CANCER
   Journal of surgical oncology
   
   K. Ito et al., "ORAL ADJUVANT CHEMOTHERAPY WITH CARMOFUR (HCFU) FOR COLORECTAL-CANCER- 5-YEAR FOLLOW-UP, TOKAI HCFU STUDY-GROUP - 3RD STUDY ON COLORECTAL-CANCER", Journal of surgical oncology, 63(2), 1996, pp. 107-111
10. ITO K; YAMAGUCHI A; MIURA K; KATO T; KOIKE A; TAKAGI H
    PROSPECTIVE ADJUVANT THERAPY WITH MITOMYCIN-C AND CAUMOFUR (HCFU) FORCOLORECTAL-CANCER, 10-YEAR FOLLOW-UP - TOKAI HCFU STUDY-GROUP, THE FIRST STUDY FOR COLORECTAL-CANCER
    Journal of surgical oncology
    
    K. Ito et al., "PROSPECTIVE ADJUVANT THERAPY WITH MITOMYCIN-C AND CAUMOFUR (HCFU) FORCOLORECTAL-CANCER, 10-YEAR FOLLOW-UP - TOKAI HCFU STUDY-GROUP, THE FIRST STUDY FOR COLORECTAL-CANCER", Journal of surgical oncology, 62(1), 1996, pp. 4-9
11. MATSUMOTO S; NISHIZAWA S; MURAKAMI M; NOMA S; SANO A; KURODA Y
    CARMOFUR-INDUCED LEUKAENCEPHALOPATHY - MRI
    Neuroradiology
    
    S. Matsumoto et al., "CARMOFUR-INDUCED LEUKAENCEPHALOPATHY - MRI", Neuroradiology, 37(8), 1995, pp. 649-652